Healthy smokers at risk for cardiovascular disease: the usefullness of left ventricular function and metabolic status evaluation.

C. Vicol (VALEA LUPULUI/ IASI, Romania)

Source: International Congress 2017 – Smoking and health hazards
Session: Smoking and health hazards
Session type: Poster Discussion
Number: 2984
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Vicol (VALEA LUPULUI/ IASI, Romania). Healthy smokers at risk for cardiovascular disease: the usefullness of left ventricular function and metabolic status evaluation.. 2984

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Is there benefit from proactive case-detection of left ventricular systolic dysfunction (LVSD) using BNP in patients with advanced COPD?
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016


Pulmonary hypertension associated with left heart disease: efforts to improve the meaning of haemodynamic phenotypes
Source: Eur Respir J, 53 (3) 1802393; 10.1183/13993003.02393-2018
Year: 2019



Pulmonary hypertension associated with left heart disease: efforts to improve the meaning of haemodynamic phenotypes
Source: Eur Respir J, 53 (3) 1801894; 10.1183/13993003.01894-2018
Year: 2019



Haemodynamics to predict outcome in pulmonary hypertension due to left heart disease: a meta-analysis
Source: Eur Respir J, 51 (4) 1702427; 10.1183/13993003.02427-2017
Year: 2018



Assessment of atrial arrhythmogenic risk factors with body surface potential mapping in COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 351s
Year: 2005

Assessment of pulmonary function stratifies global coronary heart disease risk
Source: Annual Congress 2009 - Methodological aspects of asthma and COPD epidemiology
Year: 2009

Prevalence and impact of small airways dysfunction in patients with ischemic heart disease
Source: International Congress 2014 – Pathophysiological mechanisms at different scales
Year: 2014

Relation between hemodynamics and right ventricular hypertrophy may affect survival and severity of the disease in patients with primary pulmonary hypertension (PPH)
Source: Eur Respir J 2002; 20: Suppl. 38, 26s
Year: 2002

Prevalence of lung function abnormalities in smokers with ischemic heart disease
Source: International Congress 2019 – Cardiovascular comorbidities in COPD
Year: 2019

Pulmonary hemodynamics and remodeling of the right heart in patients with COPD, depending on the risk group.
Source: International Congress 2019 – Cardiovascular comorbidities in COPD
Year: 2019

Right ventricular diastolic function in patients with COPD and heart failure, depending on endothelial function
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013

Predictors for high ventricular arrhythmia burden in patients with heart failure with reduced ejection fraction and central sleep apnea: an analysis of the SERVE-HF major substudy
Source: Sleep and Breathing Conference 2021
Year: 2021




Impact of pulmonary function on cardiovascular disease events in persons with metabolic syndrome and diabetes
Source: Annual Congress 2011 - Comorbidities and impact on society of asthma and COPD
Year: 2011


Late Breaking Abstract - Right heart structural changes, exercise capacity and stress induced right ventricle dysfunction in non- severe COPD patients without pulmonary hypertension at rest.
Source: International Congress 2018 – New determinants of cardiovascular morbidity in COPD
Year: 2018

Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: role of the pre-capillary component
Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension
Year: 2017

Impaired pulmonary function and its association with clinical outcomes, exercise capacity and quality of life in children with congenital heart disease
Source: Virtual Congress 2020 – Clinical year in review
Year: 2020

Cardiovascular comorbidities based on impaired pulmonary function in non-smoking population
Source: Virtual Congress 2020 – Airflow obstruction, COPD and comorbidities
Year: 2020


Ventilatory function as predictor of cardio-metabolic markers of cardiovascular disease: 10 year follow-up in young adults
Source: International Congress 2015 – COPD and lung function: risk factors and outcomes
Year: 2015

Association between lung function and future risks of diabetes, asthma, myocardial infarction, hypertension and all-cause mortality
Source: ERJ Open Res, 7 (3) 00178-2021; 10.1183/23120541.00178-2021
Year: 2021



MPAP/CO-slope during exercise as predictor of mortality in patients at risk for pulmonary hypertension.
Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension
Year: 2020